Tag Archives: HDT-NET

Successful start of our 2 new trials in Tbilisi, Georgia

We spent last tweek in Tbilisi, Georgia, to prepare the start of our 2 new CT to evaluate hostdirected therapies: ibuprofen and the nutraceutical Nyaditum resae. A pilot CT will evaluate ibuprofen as coadjuvant treatment for Pre-XDR and XDR-TB; and … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | Leave a comment

A next step in the Host-Directed Therapies field

We are happy to announce that we are going to conduct a pilot clinical trial in the NCTLD in Tbilisi, Georgia to evaluate the potential benefit and safety of ibuprofen as coadjuvant in the treatment of XDR-TB cases. The study … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

New article on Host-Directed Therapies by the HDT-NET

The UTE has participated in a new article published in the Clinical Infectious Diseases journal, a new achievement of the The Host-Directed Therapies Network (HDT-NET).  This new paper is leaded by Pr Zumla and Pr Maeurer, and explains why this consortium is needed, … Continue reading

Posted in Uncategorized | Tagged , , , , , | Leave a comment